Business Context and Reporting Period
This Form 8-K is a current report filed by Medtronic Plc on June 29, 2016. The filing addresses Item 5.02 regarding the appointment of certain officers and compensatory arrangements.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to specific executive compensation awards.
Material Changes
The Compensation Committee approved one-time awards of time-based restricted stock units (RSUs) to two executives:
- Michael J. Coyle, Executive Vice President and President, Cardiac and Vascular Group.
- Bryan C. Hanson, Executive Vice President and President, Minimally Invasive Therapies Group.
Each executive will receive RSUs with a value of $4.0 million on the grant date, expected to be August 1, 2016.
Guidance, Outlook, and Conditions
The awards are subject to the following conditions:
- Medtronic must attain certain earnings per share thresholds.
- Executives must maintain continued employment with Medtronic.
- Awards are subject to standard forfeiture and clawback provisions for equity awards.
The filing does not contain updated financial guidance, management commentary on operations, or discussions of risks and contingencies beyond the standard terms of the equity awards.
Investor Verification Points
- Verify the specific earnings per share thresholds required for the RSU awards to vest.
- Confirm the exact grant date and the share price used to calculate the $4.0 million value per executive.
- Review the Medtronic plc Amended and Restated 2013 Stock Award and Incentive Plan for detailed forfeiture and clawback terms.